Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group (Q73562809)
Jump to navigation
Jump to search
scientific article published on 01 January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group |
scientific article published on 01 January 1997 |
Statements
Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group (English)
T M Beck
M York
A Chang
R Navari
W H Harvey
M Meshad
D Griffin